Albira Tablet

Adult dose

Generally, take 2 tablets orally, twice a day, before breakfast and at bedtime, irrespective of meals. 1) Gastric and duodenal ulcers: administer 2 tablets twice daily or 4 tablets once daily before bedtime. For duodenal ulcer patients, administer 4 tablets twice daily before breakfast and at bedtime. 2) Gastroesophageal reflux disease: administer 2 tablets twice daily for 8 weeks or 4 tablets once daily before bedtime. In severe cases, the dosage can be increased to 4 tablets four times a day. 3) Zollinger-Ellison syndrome: start treatment with an initial dose of 2 tablets three times daily and adjust the dosage as needed. In severe cases, according to the physician's instructions, 6 g of ranitidine can be given per day. 4) Peptic ulcers, acute stress ulcers, and upper gastrointestinal bleeding due to acute gastric mucosal lesions: switch to oral administration of 2 tablets twice daily once oral administration becomes possible. 5) Preoperative medication (to prevent Mendelson's syndrome): administer 2 tablets 2 hours prior to anesthesia. In this case, it is also beneficial to take 2 tablets the night before surgery.

This medication should not be used in patients receiving dialysis treatment or those who have had an allergic reaction to this medication or its components. It is also advisable not to administer it to patients with a history of acute porphyria, those with impaired renal function, those who have undergone gastrointestinal surgery, pregnant women or those who may become pregnant, premature infants, and newborns, and patients on a potassium-restricted diet. Patients with liver dysfunction, those who have had hypersensitivity reactions to drugs, the elderly, those with a history of renal impairment, and patients taking NSAIDs should be closely monitored while using this medication. It can conceal symptoms of stomach cancer, so patients with gastric ulcers or middle-aged or older patients who have newly developed or changed dyspeptic symptoms must verify the possibility of malignancy before taking it. Patients with gastric or duodenal ulcers infected with Helicobacter pylori must also undergo treatment to eradicate the bacteria. Special care is needed for patients in severe intensive care units, those with hypophosphatemia, and those who have difficulty swallowing. Rarely, serious allergic reactions, skin rashes, blood abnormalities, liver dysfunction, cardiac arrhythmias, digestive disorders, and neurological symptoms may occur during the use of this medication, so if any abnormal symptoms occur, it is important to consult a doctor immediately. If there is no therapeutic effect without long-term use, it is preferable to switch to another medication, and it is important to have regular blood tests and assess liver and kidney function. Elderly patients or those with chronic lung diseases, diabetes, or weakened immune systems may have an increased risk of pneumonia while taking this medication, so caution is required. If dizziness or drowsiness occurs while taking this medication, it is advised to avoid driving or operating hazardous machinery. This medication can affect the absorption or metabolism of other drugs; therefore, if taking other medications, it is essential to inform your doctor or pharmacist, especially when taken with anticoagulants or antibiotics. It is safest not to use this medication during pregnancy or while breastfeeding, and safety in pediatric patients has not been established, so it is advisable not to administer it. In cases of overdose, emergency treatments such as vomiting or gastric lavage may be necessary; in some cases, hemodialysis may be helpful. This medication reduces gastric acid secretion, which may promote bacterial growth in the stomach; therefore, it is advised to have an eye examination during long-term use.

Serious side effects

Hives, severe swelling (including angioedema), chest tightness, difficulty breathing, cold sweat, pallor, anaphylactic shock, severe allergic reactions, severe skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis), shortness of breath or asthma attacks, dyspnea, liver dysfunction (including jaundice), reversible jaundice or non-jaundiced hepatitis, severe neurological symptoms (severe headache, seizures, confusion), severe adverse reactions

Mild side effects

• Skin rash
• angioedema
• fever
• hypotension
• chest pain
• granulocytopenia
• leukopenia
• thrombocytopenia
• elevated serum enzyme levels
• nausea

This medication should be stored in a tightly sealed container to prevent air from entering, preferably at a temperature between 1 and 30 degrees Celsius. Proper storage helps maintain the efficacy of the medication.

Appearance

White, round film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle